CC BY-NC-ND 4.0 · Geburtshilfe Frauenheilkd 2024; 84(04): 334-345
DOI: 10.1055/a-2273-6318
GebFra Science
Review

The NFκB Signaling Pathway Is Involved in the Pathophysiological Process of Preeclampsia

Der NFκB-Signalweg ist am pathophysiologischen Prozess der Präeklampsie beteiligt
Yaxi Li
1   The First Clinical Medical College of Lanzhou University, Lanzhou, China (Ringgold ID: RIN117741)
,
Qinying Zhu
1   The First Clinical Medical College of Lanzhou University, Lanzhou, China (Ringgold ID: RIN117741)
,
Ruifen He
1   The First Clinical Medical College of Lanzhou University, Lanzhou, China (Ringgold ID: RIN117741)
,
Junhong Du
1   The First Clinical Medical College of Lanzhou University, Lanzhou, China (Ringgold ID: RIN117741)
,
Xue Qin
1   The First Clinical Medical College of Lanzhou University, Lanzhou, China (Ringgold ID: RIN117741)
,
Yi Li
1   The First Clinical Medical College of Lanzhou University, Lanzhou, China (Ringgold ID: RIN117741)
,
Xiaolei Liang
2   Department of Obstetrics and Gynecology, Key Laboratory for Gynecologic Oncology Gansu Province, The First Hospital of Lanzhou University, Lanzhou, China (Ringgold ID: RIN117741)
,
3   Department of Obstetrics and Gynecology, The First Hospital of Lanzhou University, Lanzhou, China (Ringgold ID: RIN117741)
› Author Affiliations
Supported by: First Clinical Medical School, Lanzhou University No. ldyyyn2022-16

Abstract

The high prevalence of preeclampsia (PE) is a major cause of maternal and fetal mortality and affects the long-term prognosis of both mother and baby. Termination of pregnancy is currently the only effective treatment for PE, so there is an urgent need for research into its pathogenesis and the development of new therapeutic approaches. The NFκB family of transcription factors has an essential role in inflammation and innate immunity. In this review, we summarize the role of NFκB in normal and preeclampsia pregnancies, the role of NFκB in existing treatment strategies, and potential NFκB treatment strategies.

Zusammenfassung

Die hohe Prävalenz von Präeklampsie (PE) ist eine wesentliche Ursache mütterlicher und fetaler Mortalität und wirkt sich auch auf die Langzeitprognose von Mutter und Kind aus. Der Schwangerschaftsabbruch stellt zurzeit die einzig effektive Therapie gegen PE dar. Damit besteht ein dringender Bedarf nach weiterer Forschung zur Pathogenese von PE sowie zur Entwicklung neuer Therapieansätze. Die NFκB-Familie der Transkriptionsfaktoren spielt eine wichtige Rolle in Entzündungsprozessen und für die angeborene Immunität. In dieser Übersichtsstudie fassen wir die Rolle von NFκB bei normalen und Präeklampsie-Schwangerschaften sowie die Bedeutung von NFκB in bereits existierenden Therapien und potenzielle NFκB-Behandlungsstrategien zusammen.



Publication History

Received: 02 November 2023

Accepted after revision: 20 February 2024

Article published online:
10 April 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany